• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人白细胞干扰素的药代动力学

Pharmacokinetics of human leukocyte interferon.

作者信息

Cantell K, Pyhälä L

出版信息

J Infect Dis. 1976 Jun;133 Suppl:A6-12. doi: 10.1093/infdis/133.supplement_2.a6.

DOI:10.1093/infdis/133.supplement_2.a6
PMID:932506
Abstract

Most of the human leukocyte interferon or rabbit serum interferon administered intravenously to rabbits was detectabble in their plasma 1 min after injection. An increase in the dose did not affect the early clearance of human interferon but did prolong its persistence in the serum. Repeated intramuscular injections had no effect on the kinetics of circulating interferon. The purity of the preparation influenced the rate at which interferon entered the blood after intramuscular or subcutaneous injection but did not affect clearance from the blood after intravenous injection. The circulating interferons obtained after intravenous or intramuscular administration cleared at similar rates. During the first 1-2 hr after intravenous or intramuscular injection into rats, the interferon levels were lower in lymph than in serum; after 2 hr lymph and serum samples contained similar amounts of interferon.

摘要

给兔子静脉注射的大多数人白细胞干扰素或兔血清干扰素在注射后1分钟可在其血浆中检测到。剂量增加不影响人干扰素的早期清除,但确实延长了其在血清中的持续时间。重复肌肉注射对循环干扰素的动力学没有影响。制剂的纯度影响肌肉或皮下注射后干扰素进入血液的速率,但不影响静脉注射后从血液中的清除。静脉或肌肉给药后获得的循环干扰素以相似的速率清除。在给大鼠静脉或肌肉注射后的最初1-2小时内,淋巴中的干扰素水平低于血清中的;2小时后,淋巴和血清样本中的干扰素含量相似。

相似文献

1
Pharmacokinetics of human leukocyte interferon.人白细胞干扰素的药代动力学
J Infect Dis. 1976 Jun;133 Suppl:A6-12. doi: 10.1093/infdis/133.supplement_2.a6.
2
Comparison of rates of clearance of human fibroblast and leukocyte interferon from the circulatory system of rabbits.兔循环系统中人类成纤维细胞干扰素和白细胞干扰素清除率的比较。
J Infect Dis. 1976 Jun;133 Suppl:A18-21. doi: 10.1093/infdis/133.supplement_2.a18.
3
[Pharmacokinetics of human interferons].[人类干扰素的药代动力学]
Gan To Kagaku Ryoho. 1984 Apr;11(4):935-42.
4
Circulating interferon in rabbits and monkeys after administration of human gamma interferon by different routes.通过不同途径给兔和猴注射人γ干扰素后其体内循环干扰素的情况。
J Gen Virol. 1983 Aug;64 (Pt 8):1823-6. doi: 10.1099/0022-1317-64-8-1823.
5
Pharmacokinetics of human recombinant interferon-beta in monkeys and rabbits.人重组干扰素-β在猴和兔体内的药代动力学
Gan. 1984 Mar;75(3):292-300.
6
Circulating interferon in rabbits after administration of human interferon by different routes.不同途径给予人干扰素后家兔体内循环干扰素的情况
J Gen Virol. 1973 Jul;20(1):97-104. doi: 10.1099/0022-1317-20-1-97.
7
[Distribution of human interferon in organs and tissues after its administration to man and animals].[人用干扰素给药后在人和动物体内各器官和组织中的分布]
Vopr Virusol. 1980 Sep-Oct(5):594-6.
8
The lymphatic route. V. Distribution of human natural interferon-beta in rabbit plasma and lymph.淋巴途径。五、人天然β干扰素在兔血浆和淋巴中的分布。
J Interferon Res. 1988 Oct;8(5):633-40. doi: 10.1089/jir.1988.8.633.
9
The kinetics of human interferon clearance in gibbons.长臂猿体内人干扰素清除的动力学
Proc Soc Exp Biol Med. 1973 Mar;142(3):946-7. doi: 10.3181/00379727-142-37151.
10
Circulating interferon in man after administration of exogenous human leukocyte interferon.给予外源性人白细胞干扰素后人体循环中的干扰素
J Natl Cancer Inst. 1975 May;54(5):1045-9.

引用本文的文献

1
Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits.人成纤维细胞和白细胞干扰素在兔体内的药代动力学特性。
J Clin Microbiol. 1980 Jan;11(1):102-5. doi: 10.1128/jcm.11.1.102-105.1980.
2
Biosynthetic human interferon treatment of herpetic keratitis.生物合成人干扰素治疗疱疹性角膜炎。
Trans Am Ophthalmol Soc. 1983;81:785-824.
3
The treatment of cancer patients with human lymphoblastoid interferon. A comparison of two routes of administration.用人淋巴母细胞干扰素治疗癌症患者。两种给药途径的比较。
Cancer Immunol Immunother. 1983;15(2):144-8. doi: 10.1007/BF00199706.
4
Interferon therapy: pharmacokinetic and pharmacological aspects.干扰素治疗:药代动力学和药理学方面。
Arch Virol. 1981;67(2):121-33. doi: 10.1007/BF01318595.
5
Receptor mediated pathways for interferon action: in vivo implications.
Med Oncol Tumor Pharmacother. 1984;1(2):77-85. doi: 10.1007/BF02934978.
6
The lymphatic route. 1) Albumin and hyaluronidase modify the normal distribution of interferon in lymph and plasma.
Experientia. 1986 Apr 15;42(4):432-3. doi: 10.1007/BF02118644.
7
Interferons: anti-neoplastic drugs?干扰素:抗肿瘤药物?
Blut. 1977 Sep 18;35(4):277-88. doi: 10.1007/BF00996140.
8
Biological properties of mouse interferon bound to a high molecular weight carrier: Blue Dextran 2000.与高分子量载体结合的小鼠干扰素的生物学特性:蓝色葡聚糖2000
Arch Virol. 1979;60(1):43-50. doi: 10.1007/BF01318096.